Keywords: ACEI; angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; DM; diabetes mellitus; eGFR; estimated glomerular filtration rate; EHR; electronic health record; ESRD; end-stage renal disease; FSGS; focal segmental glomerulosclerosis; GN